Wolfgang Simon

Breast Cancer Treatment Outcome With Adjuvant Tamoxifen Relative to Patient CYP2D6 and CYP2C19 Genotypes

Werner Schroth, Lydia Antoniadou, Péter Fritz et al. · Journal of Clinical Oncology · 2007 · 466 citations

Medicine, Oncology, Pharmacology +17

Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma

T E Mürdter, Werner Schroth, L. Bacchus-Gerybadze et al. · Clinical Pharmacology & Therapeutics · 2011 · 268 citations

Medicine, Pharmacokinetics, Pharmacology +17

Enkephalin effects on blood pressure, heart rate, and baroreceptor reflex.

K. Schaz, G. Stock, Wolfgang Simon et al. · Hypertension · 1980 · 199 citations

Medicine, Neuroscience, Pharmacology +14

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)

Gϋnter von Minckwitz, Gϋnter von Minckwitz, Sibylle Loibl et al. · Annals of Oncology · 2014 · 140 citations

Medicine, Oncology, Pharmacology +15

Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment

Heiko van der Kuip, Thomas E. Mürdter, Maike Sonnenberg et al. · BMC Cancer · 2006 · 110 citations · Full text

Medicine, Oncology, Pharmacology +17